The global sports drug testing market size is expected to be valued at US$ 13.4 Billion in 2022 and reach US$ 20.6 Billion in 2032. Implementation of stringent norms by government bodies mandating alcohol and drug testing worldwide is likely to augment growth in the upcoming decade.
As per FMI, the sports drug testing market is anticipated to exhibit steady growth at a CAGR of 17.5% in the forecast period from 2022 to 2032. Increasing regulatory approvals for drug screening services and products, as well as high consumption of alcohol would drive the demand for sports drug testing solutions.
| Report Attribute | Key Statistics |
|---|---|
| Sports Drug Testing Market Estimated Base Year Value (2021) | US$ 12.8 Billion |
| Sports Drug Testing Market Expected Market Value (2022) | US$ 13.4 Billion |
| Sports Drug Testing Market Anticipated Forecast Value (2032) | US$ 20.6 Billion |
| Sports Drug Testing Market Projected Growth Rate (2022 to 2032) | 17.5% CAGR |
The emergence of fingerprint-based drug testing is expected to create new growth opportunities for key players in the market. These tests are user-friendly, hygienic, less time-consuming, portable, and noninvasive, and require no specific preparation for sample handling and collection.
Fingerprint-based drug testing solutions provide high effectiveness and flexibility. These are capable of analyzing small traces of sweat on fingertips to detect drug metabolites and drugs. Increasing usage of these tests in various places such as sports arenas, criminal justice, drug rehabilitation programs, and workplaces is likely to aid growth.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increasing consumption of illicit drugs among the young population is one of the vital factors that is projected to boost the global sports drug testing market growth in future. High crime rates related to drug abuse are also set to spur the adoption of novel drug-testing devices in various parts of the globe.
As per the World Health Organization (WHO), in 2019, approximately 180 thousand deaths were directly associated with drug use disorders across the globe and about 35 million people are estimated to be living with drug use disorders at present.
These numbers are likely to surge in the next decade with the easy availability of illegal drugs, including amphetamine, heroin, cocaine, methadone, cannabis, and methamphetamines worldwide. Spurred by the aforementioned factors, the global market is expected to grow at a rapid pace.
A drug testing program can lead to the loss of otherwise qualified athletes who fail random drug tests but have not caused any trouble. Use of marijuana either recreational or medical is legal in certain states. However, it is still illegal at the federal level and this factor can complicate things for athletes coming from these states who may have been using marijuana within their legal guidelines.
Further, it can complicate things if some athletes are treated differently as they live in one of those states than others who also test positive for marijuana. There could still be complications if marijuana is consumed as a prescribed substance for the treatment of a particular disease, yet it is used as a disqualifier for sports. The above-mentioned limitations may hinder the global sports drug testing market size in the evaluation period.
Principal Consultant
North America is projected to lead in the assessment period by generating the largest sports drug testing market share. The presence of a large number of key players in the U.S. and Canada and strict norms mandating workplace testing are some of the crucial factors that would push growth in the regional market.
Moreover, favourable reimbursement policies and the growing use of technologically advanced drug testing solutions across North America are anticipated to aid growth. According to the National Center for Drug Abuse Statistics, in the U.S., drug overdose deaths were nearing 1 million in 2000 and the federal budget for drug control was US$ 35 million in 2020.
The organization further mentioned that as of 2020, about 37.309 million Americans belonging to the age group of 12 years and above were illegal drug users, whereas approximately 50.0% of people aged 12 years and above have used drugs in their lifetime illicitly in the country. The trends are estimated to continue throughout the forthcoming years, thereby pushing sales across North America.
Sales of sports drug testing products in Asia Pacific are anticipated to surge at a considerable pace on the back of the increasing prevalence of drug-related crimes and substance abuse disorders in emerging economies, including India and China. A rising number of drug testing laboratories across South Korea, Japan, and Singapore to test the presence of any illicit substance and provide accurate results is also projected to foster growth.
Besides, the availability of sophisticated equipment like spectroscopy and high-performance liquid chromatography (HPLC), as well as skilled personnel for conducting tests to get effective results is set to propel the regional market. Ongoing development of rapid point-of-care urine tests for detecting commonly abused prescription medications, including oxycodone, methadone, opiates, benzodiazepines, and buprenorphine is also likely to fuel growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the leading companies present in the global sports drug testing market include Quest Diagnostics Incorporated, Siemens Healthcare GmbH, Idexx Laboratories, Dragerwerk AG & Co. KGaA, Pz Cormay, Shimadzu Corporation, Lifeloc Technologies Inc., JMB Enterprises Inc., Alere, Inc., and Thermo Fisher Scientific Inc. among others.
Leading players are focusing on various organic and inorganic growth strategies such as geographical expansion, mergers and acquisitions, and new product development to generate a high share in the global market. Meanwhile, a few other key players are investing in research and development activities to come up with innovative products and increase sales.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 17.5% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
The global sports drug testing market is set to exceed US$ 20.6 Bn in 2032.
North America is set to lead the sports drug testing market in the forecast period.
Quest Diagnostics Incorporated, Siemens Healthcare GmbH, Idexx Laboratories, Dragerwerk AG & Co. KGaA, Pz Cormay, and Shimadzu Corporation are some of the renowned companies in the sports drug testing market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Sports Drug Testing Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Sports Drug Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032 5.3.1. Equipment 5.3.1.1. Immunoassay Analyzers 5.3.1.2. Chromatography Instruments 5.3.1.3. Alcohol Breath Analyzers 5.3.1.4. Rapid Testing Devices 5.3.1.5. Urine Testing Devices 5.3.1.6. Oral Fluid Testing Devices 5.3.2. Consumables 5.3.3. Assay Kits 5.3.4. Sample Collection Cups 5.3.5. Others 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 6. Global Sports Drug Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Sample Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Sample Type, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Sample Type, 2022-2032 6.3.1. Urine 6.3.2. Blood 6.3.3. Oral Fluid 6.3.4. Breath 6.3.5. Hair 6.3.6. Others 6.4. Y-o-Y Growth Trend Analysis By Sample Type, 2017-2021 6.5. Absolute $ Opportunity Analysis By Sample Type, 2022-2032 7. Global Sports Drug Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032 7.3.1. Hospitals 7.3.2. Government Departments 7.3.3. Drug Rehabilitation Centers 7.3.4. Pain Management Centers 7.3.5. Drug Testing Laboratories 7.3.6. Others 7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 7.5. Absolute $ Opportunity Analysis By End User, 2022-2032 8. Global Sports Drug Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Sports Drug Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Sample Type 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Sample Type 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Sports Drug Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Sample Type 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Sample Type 10.3.4. By End User 10.4. Key Takeaways 11. Europe Sports Drug Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. U.K. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Product Type 11.2.3. By Sample Type 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Sample Type 11.3.4. By End User 11.4. Key Takeaways 12. Asia Pacific Sports Drug Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Malaysia 12.2.1.5. Singapore 12.2.1.6. Australia 12.2.1.7. Rest of Asia Pacific 12.2.2. By Product Type 12.2.3. By Sample Type 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Sample Type 12.3.4. By End User 12.4. Key Takeaways 13. MEA Sports Drug Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Product Type 13.2.3. By Sample Type 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Sample Type 13.3.4. By End User 13.4. Key Takeaways 14. Key Countries Sports Drug Testing Market Analysis 14.1. U.K. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Product Type 14.1.2.2. By Sample Type 14.1.2.3. By End User 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Product Type 14.2.2.2. By Sample Type 14.2.2.3. By End User 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Product Type 14.3.2.2. By Sample Type 14.3.2.3. By End User 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Product Type 14.4.2.2. By Sample Type 14.4.2.3. By End User 14.5. Rest of Latin America 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Product Type 14.5.2.2. By Sample Type 14.5.2.3. By End User 14.6. Germany 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Product Type 14.6.2.2. By Sample Type 14.6.2.3. By End User 14.7. U.K. 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Product Type 14.7.2.2. By Sample Type 14.7.2.3. By End User 14.8. France 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Product Type 14.8.2.2. By Sample Type 14.8.2.3. By End User 14.9. Spain 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Product Type 14.9.2.2. By Sample Type 14.9.2.3. By End User 14.10. Italy 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Product Type 14.10.2.2. By Sample Type 14.10.2.3. By End User 14.11. Rest of Europe 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Product Type 14.11.2.2. By Sample Type 14.11.2.3. By End User 14.12. China 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Product Type 14.12.2.2. By Sample Type 14.12.2.3. By End User 14.13. Japan 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Product Type 14.13.2.2. By Sample Type 14.13.2.3. By End User 14.14. South Korea 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Product Type 14.14.2.2. By Sample Type 14.14.2.3. By End User 14.15. Malaysia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Product Type 14.15.2.2. By Sample Type 14.15.2.3. By End User 14.16. Singapore 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Product Type 14.16.2.2. By Sample Type 14.16.2.3. By End User 14.17. Australia 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Product Type 14.17.2.2. By Sample Type 14.17.2.3. By End User 14.18. Rest of Asia Pacific 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Product Type 14.18.2.2. By Sample Type 14.18.2.3. By End User 14.19. GCC Countries 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Product Type 14.19.2.2. By Sample Type 14.19.2.3. By End User 14.20. South Africa 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2021 14.20.2.1. By Product Type 14.20.2.2. By Sample Type 14.20.2.3. By End User 14.21. Israel 14.21.1. Pricing Analysis 14.21.2. Market Share Analysis, 2021 14.21.2.1. By Product Type 14.21.2.2. By Sample Type 14.21.2.3. By End User 14.22. Rest of MEA 14.22.1. Pricing Analysis 14.22.2. Market Share Analysis, 2021 14.22.2.1. By Product Type 14.22.2.2. By Sample Type 14.22.2.3. By End User 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Product Type 15.3.3. By Sample Type 15.3.4. By End User 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Siemens Healthcare GmbH 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.2. Dragerwerk AG & Co. KGaA 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.3. JMB Enterprises Inc. 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.4. Shimadzu Corporation 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.5. Thermo Fisher Scientific Inc. 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.6. Quest Diagnostics Incorporated 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.7. Alere 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.8. Lifeloc Technologies Inc. 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.9. Pz Cormay 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.10. Idexx Laboratories 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports
Sports Drug Testing Market
